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Abstract Most conditions associated with ageing result
from an age-related loss in the function of cells and
tissues that maintain body homeostasis. In osteoarthritis
(OA) patients, an inadequate response to stress or joint
injury can lead to tissue destruction which can result in
chronic pain. Here, we evaluated the development of
monoiodoacetate (MIA)-induced OA in 3-, 15- and 22-
month-old mice and assessed the pain-like behaviours
and the spinal microglial changes associated with MIA
administration. We observed that in aged mice,
nocifensive behaviour was significantly attenuated in
comparison to young adults despite similar knee joint
pathology. Specifically referred mechanical allodynia
associated with the MIA initial inflammatory phase
(0–10 days) was significantly attenuated in 22-month-
old mice. In contrast, the late phase of MIA-induced
mechanical allodynia was comparable between age
groups. Significant increase of microglia cell numbers
was detected in 3, but not 15- and 22-month-old spinal
cords. Furthermore, in the zymosan model of acute
inflammation, mechanical allodynia was attenuated,
and microglial response was less robust in 22 compared
to 3-month-old mice. This study suggests that
nocifensive responses to damaging stimuli are altered
with advancing age and microglial response to periph-
eral damage is less robust.
Keywords Osteoarthritis . Pain .Microglia
Introduction
The main risk factor for osteoarthritis (OA) is age, and
people over 65 years commonly display radiographic
changes of OA, particularly osteophytes, in their joints
(Goekoop et al. 2011). Clinical OA is defined by features
in patient history and upon examination, requiring the
presence of joint pain (Oliveria et al. 1995; Jinks et al.
2007). Chronic pain conditions are more prevalent in the
elderly, and pain perception is altered with ageing (Gibson
and Farrell 2004). As there are currently no disease-
modifying therapies for OA, treatment is aimed at man-
aging the symptoms of pain and swelling, trying to min-
imise functional impairment to maintain quality of life.
Analgesics that are currently recommended for treatment
of OA pain include paracetamol, NSAIDs, opioids and
cyclooxygenase (COX)-2-selective inhibitors (coxibs)
(Eccles et al. 1998; Geba et al. 2002; Jawad 2005).
Most conditions associated with ageing result from
an age-related loss in function of cells and tissues to
maintain body homeostasis, especially when placed un-
der stress. In OA patients, an inadequate response to
stress or joint injury can lead to joint tissue destruction.
How this joint destruction might then result in pain
development can also be affected by age; both periph-
eral and central components of the nociceptive pathway
show age-related changes (Gibson and Farrell 2004).
Indeed, peripheral nerves in aged subjects display al-
tered functional, structural and biochemical properties
such as slower axonal regeneration after injury (Verdu
et al. 2000). There are also age-related changes centrally
that result in hyperexcitability within the dorsal horn of
the spinal cord and impaired descending modulation
(Iwata et al. 2002). Both neuronal sensitisation at the
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site of joint damage in the periphery (peripheral sensiti-
zation) (Schaible et al. 2009) and centrally in the dorsal
horn of the spinal cord (central sensitization) contribute
to chronic pain mechanisms (Schaible 2006). OA is
considered as a progressive degenerative process which
is tightly integrated with inflammation. Therefore, the
age-related alterations to the peripheral and central sen-
sory pathway offer reasoning behind the increased inci-
dence of painful chronic conditions such as OA.
Peripheral inflammation is associated with sensitisation
of nociceptive afferent fibres in the joint by pro-
inflammatorymediators which results in reduced thresh-
old of fibre activation, increased firing and increased
fibre input centrally in the dorsal horn of the spinal cord.
The responsiveness of spinal dorsal horn neurons to
mechanical and heat stimuli applied to the periphery,
background activity, after-discharge and receptive fields
are significantly enhanced after inflammation (Schaible
and Schmidt 1988; Grubb et al. 1993; Iwata et al. 1999;
Iwata et al. 2002). Besides central neuron sensitization, a
microglial response in the spinal cord has been observed
in models of peripheral inflammation (Svensson et al.
2003; Clark et al. 2007; Staniland et al. 2010; Clark et al.
2012). Similarly, spinal and brain microglia acquire an
activated morphology during normal ageing (Streit and
Xue 2009) and can release pro-inflammatory mediators
capable of enhancing nociceptive transmission.
In this study, we employed a mouse model of OA in
which a single injection of monoiodoacetate (MIA) is
delivered to the knee joint, inducing peripheral changes
that include local acute inflammation followed by carti-
lage erosion, joint disruption and increased pro-
inflammatory cytokine expression in the joint (Bove
et al. 2003; Guzman et al. 2003; Fernihough et al.
2004; Orita et al. 2011). There is also evidence of central
changes that include spinal cord neuronal and microglial
activation, as well as increased nociceptive neuropep-
tide release evoked by activation of the central terminal
of primary afferents into the dorsal horn (Ogbonna et al.
2013; Rahman and Dickenson 2015). The contribution
of microglial activation is suggested by the observation
that repeated administration of the microglia inhibitor,
minocycline, attenuated pain behaviour and reduced the
number of activated microglia in the spinal cord of
MIA-treated rats (Sagar et al. 2011).
Specifically, in the current study, we evaluated the
development of MIA-induced OA in 3-, 15- and 22-
month-old mice with the following two objectives: first,
to assess the pain-like behaviours associated with MIA
administration. Second, to assess potential changes of
spinal microglial response which is considered a mea-
sure of central activity after peripheral damage.
Materials and methods
Animals
All experiments were carried out in accordance with UK
Home Office Regulations (Animal Scientific
Procedures Act, 1986) using male adult C57Bl/6 mice
aged 3, 15 or 22 months old (20–40 g, Charles River,
UK). Food and water were available ad libitum, and
mice were housed under standard conditions with a 12-h
light/dark cycle for a week prior to behavioural experi-
ments to acclimatize. Experimental study groups were
randomized, and experiments were performed by an
observer unaware of treatments.
Monosodium iodoacetate model of osteoarthritis
As previously described (Ogbonna et al. 2013), mice
were anaesthetised by isoflurane/O2 inhalation and re-
ceived a single intra-articular injection into the left knee
of 1 mg of monosodium iodoacetate (MIA) (Sigma,
UK) in a total volume of 10 μl of physiological sterile
saline. The left leg was flexed at a 90° angle at the knee,
and the solution was injected through the intrapatellar
ligament using a 30-G needle and a Hamilton syringe.
Control mice received an intra-articular injection of
sterile saline (10 μl). In our previous study, we
established that 1 mg MIA induces pain-like behaviour
from 3 days from intra-articular injection (Ogbonna
et al. 2013). At 4 weeks from MIA injection, the knee
joints display loss of cartilage and proteoglycan staining
compared to contralateral and control knee joints
(Ogbonna et al. 2013).
Intraplantar zymosan model of inflammatory pain
As described previously (Staniland et al. 2010), the
intra-plantar zymosan model of inflammation consisted
in the injection of 20 μl of zymosan (0.2 mg/ml in
saline; Zymosan A from Saccharomyces cerevisiae;
Fluka Analytical, Germany) into the intraplantar surface
of the right hind paw. The time interval of 24 h after
injection was selected to investigate pain behaviour.
Zymosan was injected under isofluorane (Abbott
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Animal Health, UK) inhalation anaesthesia using a
500-μl U-100 microfine insulin syringe with a 29 gauge
needle (Becton, Dickinson&Co, UK).Mechanical (von
Frey hairs) and thermal (Hargreaves method) nocicep-
tive thresholds were measured on three occasions
(baseline) prior to and 24 h after zymosan injection.
Behavioural testing
Weight bearing asymmetry
Changes in weight bearing were assessed as a measure
of primary pain-related hypersensitivity. The weight
borne by each hind limb was measured using an
Incapacitance Tester (Linton Instruments, Norfolk,
UK) as previously described (Ogbonna et al. 2013).
Mice were placed in a Perspex chamber designed so
that their two hindpaws were resting on separate trans-
ducer pads. Once the mice were settled in the correct
position, a reading of their weight distribution over the
two paws was taken over 3 s. Results were calculated as
weight borne on the ipsilateral hindlimb as a percentage
of total weight borne by the mouse using the formula:
[ipsilateral weight borne / (ipsilateral+contralateral
weight borne)]×100. A value of 50 % represents an
equal weight distribution across ipsilateral and contra-
lateral hindlimbs, and a value of less than 50 % is
indicative of a reduction in weight borne on the ipsilat-
eral hind limb. Two baseline trials were recorded prior to
injection of MIA/vehicle. Mice were subsequently
assessed on days 3, 7, 10, 14, 17, 21 and 28 after
injection. Each session consisted of three separate trials
separated by at least 5 min.
Mechanical hypersensitivity
Static mechanical withdrawal thresholds were assessed
by applying calibrated von Frey hairs (0.008–1 g, Touch
Test, Stoelting, Wood Dale, IL, USA) to the plantar
surface of the hindpaw according to the ‘up-down’
method (Chaplan et al. 1994), as previously described
(Ogbonna et al. 2013). Unrestrained mice were acclima-
tized in acrylic cubicles (8×5×10 cm) on a wire mesh
grid, giving access to the underside of their paws, for up
to 60min prior to testing. Calibrated von Frey hairs were
then applied to the plantar surface of the hindpaw until
the fibre was bent. The hair was held in place for 3 s or
until the paw was withdrawn in a reflex not coupled to
movement or grooming. Each test started with
application of the 0.6-g filament (middle of the series
of 10 hairs), and each hindpaw was assessed alternately.
If the mouse withdrew its paw, the next lower force was
applied and vice versa until there was a change in
response from the mouse. Four successive hairs were
then assessed according to the up-down sequence with
no hair filament applied more than three times in order
not to sensitize the paw. The 50% pawwithdrawal value
was calculated using the method described by Dixon
(1980). Three baseline measurements were made prior
to administration of MIA/vehicle, and mice were then
subsequently assessed on days 3, 7, 10, 14, 17, 21 and
28 after injection.
Thermal hypersensitivity
Heat-pain threshold of the hind paw was determined
with the Hargreaves method using the Plantar Test
(7370; intensity 50; Ugo Basile, Italy). Unrestrained
animals were acclimatised in acrylic cubicles (8×5×
10 cm) atop a uniform glass surface for up to 60 min
prior to testing. An infrared light source was directed
onto the plantar surface of the hind paw, and the latency
to paw withdrawal was automatically measured in sec-
onds. Three responses were recorded for each hind paw
on each testing occasion with at least 1 min between
stimuli. To avoid tissue injury, the maximum stimulus
latency was 23 s.
Behavioural analysis
All data were analysed using SigmaPlot 11 (Systat
Software Inc, UK) and statistically compared using
two-way repeated measure (RM) ANOVA followed by
Student Newman Keuls post hoc test. Area under the
curve data were analysed by two-way ANOVA follow-
ed by Student Newman Keuls post hoc test. Data are
shown as mean±SEM, and p<0.05 was set as the level
of statistical significance.
Knee processing and histology
At the end of the behavioural studies, 4-week post-
injection of 1 mg MIA or vehicle (saline), mice were
deeply anaesthetized with sodium pentobarbital then
transcardially perfused with heparinized (1 U/ml) saline
followed by 4 % paraformaldehyde in 0.1 M phosphate
buffer. The knees were dissected out, and surrounding
muscle was trimmed. Tissues were post-fixed overnight
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and then placed in decalcifying solution (AlCl3 ·
6H2O 7 % w/v; formic acid 5 % v/v and HCl
8.5 % v/v in distilled water) for a maximum of
24 h. The decalcified knee joints were washed
overnight in 0.1 M phosphate buffer pH 7.4 and
then processed to paraffin wax. For toluidine stain-
ing, 10-μm-thick sections of tissue were cut and
mounted onto slides. Sections were then de-waxed
in xylene, rehydrated in descending concentrations
of alcohol, followed by washing in distilled water
before staining in 0.05 % toluidine blue (aq) for
5 min. Sections were then rapidly dehydrated in
four changes of absolute alcohol, cleared in xylene
and mounted under coverslips using DPX mounting
medium (VWR, UK). Histological and anatomical
evidence of joint pathology was not quantified.
Immunohistochemistry
At the end of the behavioural studies, 4-week post-
injection of 1 mg MIA or vehicle (saline), mice were
deeply anaesthetized with sodium pentobarbital then
transcardially perfused with heparinized (1 U/ml) saline
followed by 4 % paraformaldehyde in 0.1 M phosphate
buffer. Lumbar spinal cord were dissected out and post-
fixed for 2 h before being transferred to 20 % sucrose
solution (VWR) in 0.1 M phosphate buffer for 48 h at
4 °C. Tissue was mounted in optimum cutting temper-
ature embedding medium (VWR) then snap frozen with
liquid nitrogen and stored at −80 °C until further pro-
cessing. Transverse spinal cord sections (20 μm) were
cryostat cut and thaw mounted onto Superfrost plus
microscope slides (VWR). Slide-mounted spinal cord
sections were incubated overnight with primary an-
tibody solution for rabbit anti-ionized calcium-bind-
ing adaptor molecule 1 (Iba-1; 1:1000, Wako
Chemicals, Neuss, Germany), followed by fluores-
cent secondary antibody solution for 2 h (IgG-con-
jugated Alexa Fluor 488, Invitrogen Molecular
Probes, Carlsbad, CA, USA). All antibody solutions
were prepared in PBS with 0.1 % Triton X-100
(BDH, VWR, Lutterworth, UK) and 0.2 % sodium
azide (Sigma, UK). All slides were coverslipped
with Vectashield Mounting Medium containing nu-
clear marker 4 ′,6-diamidino-2-phenylindole·2HCl
(DAPI; Vector Laboratories, Peterborough, UK),
and fluorescent staining was visualized using a
Zeiss Axioplan 2 fluorescent microscope.
Quantification and analysis of immunohistochemistry
In order to determine whether microglial cell number in
the dorsal horn was altered in response to peripheral
damage, we performed quantitative assessment of Iba-1
immunoreactivity in spinal cord sections from MIA,
zymosan and saline treated mice was carried out by
counting positive profiles within the dorsal horn (aver-
age area 3×105 μm2 encompassing laminae I–V or
average area 1×104 μm2 encompassing laminae I–III).
Three spinal cord sections were evaluated per animal,
with a minimum of four animals per group, and the
experimenter was blind to treatment throughout the
duration of the quantification process. All data were
analysed using SigmaPlot 11 (Systat Software Inc,
UK) and statistically compared using two-way
ANOVA followed by Student Newman Keuls post hoc
test. Data are shown as mean±SEM, and p<0.05 was
set as the level of statistical significance.
Results
Age-related effects on MIA-induced weight bearing
asymmetry and mechanical allodynia
As we previously reported (Ogbonna et al. 2013), fol-
lowing intra-articular administration of MIA 3 month
old mice developed significant weight bearing asymme-
try compared to saline-treated mice, evidenced by a
reduction in weight borne on the ipsilateral hind limb,
peaking at day 3 (42±0.8 %) and persisting for the
duration of the study until 28 days after injection
(Fig. 1a). Furthermore, area under the curve analysis
(AUC) showed a significant reduction in AUC for 3-
month-old mice injected with MIA compared to those
injected with saline (Fig. 1d). When the weight bearing
capacity of 15-month-old mice was tested after intra-
articular injection, those injected with MIA also devel-
oped significant weight bearing asymmetry compared to
saline-treated mice, with the greatest reduction in ipsi-
lateral weight borne on day 10 (37±2.5 %) (Fig. 1b).
This was supported by a reduction in AUC values of 15-
month-oldMIA injectedmice compared to age-matched
saline-treated mice (Fig. 1d). In contrast, MIA-
associated weight bearing changes were attenuated in
22-month-old mice (Fig. 1c). Peak reduction in ipsilat-
eral weight borne did not occur until day 17 (44±1.1 %)
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and AUC analysis indicated that allodynia developed
significantly less that in 15-month-old mice (Fig. 1d).
MIA injection into the mouse knee is associated with
referred mechanical hypersensitivity in the ipsilateral
hind paw that occurs in a biphasic manner with an early
(0–10 days) and late (14–28 days) phase (Ogbonna et al.
2013). Here, this observation was confirmed in 3-
month-old mice with an initial reduction in paw with-
drawal thresholds (PWT), peaking at day 7 and a second
reduction that peaked at day 17 (Fig. 2a). AUC analysis
on the early and the late phase of mechanical hypersen-
sitivity demonstrated that MIA group values were
significantly lower than the saline group values in 3-
month-old mice (Fig. 2d, e). Interestingly, for both 15-
and 22-month-old mice, there was no significant reduc-
tion in PWT until day 10 and day 14, respectively
(Fig. 2b, c). The initial mechanical hypersensitivity ob-
served in 3-month-old mice was reduced in both groups
of aged mice, evidenced by significant difference in the
AUC values of MIA-treated mice compared to saline
controls in 22-month-old mice during the early phase
(Fig. 2d). In contrast, during the late phase, there was a
significant reduction in AUC values for MIA-treated
mice compared to saline across all age groups (Fig. 2e).
Fig. 1 Ageing affects MIA-associated weight bearing asymmetry.
a–cWeight borne on ipsilateral hind limbwas monitored at regular
intervals in 3-month (a), 15-month (b) and 22-month (c)-old mice
before and until 28 days following intra-articular injection.
***p<0.001, **p<0.01, *p<0.05 compared to saline control
group, two-way RM ANOVA post hoc Student Newman-Keuls.
d Area under the curve (AUC) analysis of weight borne
***p<0.001, **p<0.01 compared to age-matched saline control;
##p<0.01 between 15- and 22-month-old mice; two-way
ANOVA, post hoc Student Newman-Keuls. Data shown as
mean±SEM, n=10–16 mice per group
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Fig. 2 Ageing affects MIA-associated referred mechanical hypersen-
sitivity. a–cMechanical withdrawal responses of ipsilateral hind paws
were measured before and at regular intervals until 28-day post-intra-
articular injection in 3-month (a), 15-month (b) and 22-month (c)-old
mice. White bars represent the duration of the early and late phases of
mechanical hypersensitivity. ***p<0.001, **p<0.01 compared to sa-
line control group, two-way RMANOVA, post hoc Student Newman-
Keuls (d–e);AUCwas calculated for all groups from0 to10 days (early
phase;d) and from14 to 28 days (late phase; e). ***p<0.001 compared
to age-matched saline control group, ## p<0.01; #p<0.05 between
groups as indicated, two-way ANOVA, post hoc Student Newman-
Keuls. Data are shown as mean±SEM, n=10–16 mice per group
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These data demonstrate that the extent of MIA-
induced pain-like behaviour is attenuated in aged mice,
compared to young mice. Specifically, 15- and 22-
month-old mice develop an attenuated early phase of
mechanical hypersensitivity which is thought to repre-
sent the inflammatory phase of the model (Fernihough
et al. 2004).
MIA-induced cartilage degradation in the knee joint
of aged mice
Histological examination by way of toludine blue stain-
ing of knee joints 28 days following intra-articular
injections demonstrate that saline-treated knees from
both 3- and 22-month-old mice have intact and smooth
articular surfaces (Fig. 3a, c). MIA-treated knees from 3-
to 22-month-old mice displayed thinning cartilage and
loss of proteoglycan staining (Fig. 3b, d; shown with
arrows).
Age-related effects on MIA-induced microgliosis
Spinal changes associated with intra-articular injection
of MIA include a microglial response in the ipsilateral
dorsal horn associated with an increased primary affer-
ent input (Ogbonna et al. 2013). In order to determine
Fig. 3 Intra-articular MIA administration results in knee joint
pathology in young and aged mice. Toluidine blue staining of
articular cartilage from saline (a, c) and MIA (b, d) injected
ipsilateral knee joints. Smooth and intact articular surface of the
femur and tibia from 3-month (a) and 22-month (c)-old mice
injected with saline in contrast to thinning and loss of articular
integrity (indicated by arrows) in 3-month (b) and 22-month (d)-
old mice injected with 1-mg MIA. Scale bar=500 μm
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whether ageing has an effect on said microglial re-
sponse, spinal cord tissue from 3-, 15- and 22-month-
old mice was immunohistochemically assessed 28 days
after MIA/saline administration (Fig. 4). Intra-articular
injection of MIA in 3-month-old mice was associated
with a significant increase in Iba-1 expressing microglia
within the ipsilateral lumbar dorsal horn compared with
age-matched saline controls (Fig. 4a–c). The ipsilateral
expression of Iba-1 in the dorsal horn of aged 15-
(Fig. 4d–f) and 22-month (Fig. 4g–i)-old mice was
slightly enhanced after MIA injection in the knee com-
pared to age-matched saline treatment animals; howev-
er, this microglial response failed to reach significance
in the 15-month-old dorsal horn.
Taken together, these data suggest that the de-
velopment of the MIA model of OA is altered in
aged mice such that (i) weight bearing asymmetry
is attenuated; (ii) the early, inflammation-related
Fig. 4 MIA-associated microglial response is attenuated in aged
mice. Iba-1 immunoreactivity in L5 ipsilateral dorsal horn in saline
(a, d, g) andMIA-treated (b, e, h) mice 28 days after intra-articular
administration in 3- (a, b), 15- (d, e) and 22- (g, h) month-old
mice. Scale bars = 100 μm. Quantif icat ion of Iba-1
immunoreactivity in saline and MIA-treated dorsal horn 28 days
after administration in 3- (c), 15- (f) and 22- (i) month-old mice.
Data shown as mean±SEM, **p<0.01, *p<0.05 compared to
age-matched saline group, two-way ANOVA, post hoc Student
Newman-Keuls, n=4–5 spinal cords per group
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mechanical hypersensitivity is blunted; (iii) associ-
ated spinal microgliosis is reduced. These age-
related differences in behaviour and spinal plastic-
ity are observed despite similar effects of MIA
within the knee joint itself, thus suggesting that
aged mice display an impaired response to the
peripheral injection of an inflammatory agent.
Age-related effects on acute inflammatory pain
As the initial inflammatory phase of MIAwas attenuated
in aged mice, we examined the zymosan model of in-
flammatory pain in 3- and 22-month-old mice to deter-
mine if ageing affects the development of acute
inflammation. We have previously shown that intra-
plantar injection of zymosan produces hypersensitivity
to noxious stimuli and dorsal horn microglial activation
24 h after administration (Clark et al. 2007; Staniland
et al. 2010). As such, mechanical and thermal thresholds
were assessed prior to and 24-h post-zymosan adminis-
tration followed by immunohistochemical analysis of the
lumbar spinal cord. As previously observed (Staniland
et al. 2010), administration of zymosan to the hind paw
of 3-month-old mice produced both a reduction in PWT
to mechanical stimuli indicative of mechanical hypersen-
sitivity (Fig. 5a) and a reduction in paw withdrawal
latencies (PWL) to thermal stimuli, indicative of thermal
hyperalgesia (Fig. 5b). In 22-month_old mice, however,
Fig. 5 Zymosan-induced nocifensive behaviour and microglial
response are attenuated in aged mice (a–b); mechanical withdraw-
al responses (a) and thermal withdrawal latencies (b) of ipsilateral
hind paws were measured before (pre) and 24-h post-intra-plantar
injection of zymosan (Zym; 20 μL; 0.2 mg/mL). Data shown as
mean±SEM, ***p<0.001, **p<0.01, compared to baseline (pre)
threshold, two-way ANOVA, post hoc Student Newman-Keuls,
n=5 mice per group. c Quantification of Iba-1 immunoreactivity
(per 104 μm2) in ipsilateral and contralateral lumbar (L4 and L5)
dorsal horn 24 h after intraplantar zymosan administration (Zym;
20 μL; 0.2 mg/mL) compared to naive dorsal horn from age-
matched controls. d Quantification of ipsilateral Iba-1 immunore-
activity is normalised to contralateral levels. Data shown as mean
±SEM, **p<0.01, *p<0.05, compared to age-matched naive,
#p<0.05 compared to indicated group, two-way ANOVA post
hoc Student Newman-Keuls, n=5 spinal cords per group
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intra-plantar zymosan did not result in a significant re-
duction in PWT to mechanical stimuli but did signifi-
cantly lower PWL to thermal stimuli (Fig. 5a, b). There
was no significant difference for both PWL and PWT
between ages post-zymosan injection irrespective of dif-
ferences to their own baseline (Fig. 5a). The nocifensive
behaviour produced in 3-month-oldmice due to zymosan
administration was greater than the overall behavioural
results seen in the agedmice. This was evidenced by a 61
±15 and 44±8 % reduction in PWT and PWL, respec-
tively, in 3-month-old mice compared to a 34±10 and 34
±6 % reduction in PWT and PWL, respectively, in the
aged counterparts. In accordance with previous findings
(Sweitzer et al. 1999; Clark et al. 2007; Staniland et al.
2010), intra-plantar zymosan induced a significant in-
crease in Iba-1 expressing microglial cells in the dorsal
horn of 3-month-old mice (Fig. 5c); 22-month-old mice,
however, did not show a significant increase when raw
data averages were analysed (Fig. 5d). Microglial cell
numbers in the dorsal horn of 22-month-old mice were
slightly higher than in 3-month mice (Fig. 5c). When the
ipsilateral microglial number was normalised to that of
the contralateral dorsal horn, a significant increase in
microglial number was observed in 22-month-old mice,
but still to a lesser extent to that observed in 3-month-old
mice (Fig. 5d).
These data suggest that in the MIA model of OA,
aged mice display attenuated weight bearing changes,
an attenuation of early inflammation-related mechanical
hypersensitivity and reduced spinal microgliosis.
Similarly, in a model of acute inflammation, aged mice
develop less mechanical hypersensitivity and a
microglial response which is less robust than in young
adults.
Discussion
The data obtained in this study demonstrate that ageing
is associated with changes in the development of
nocifensive behaviours in the MIA model of OA.
Specifically, 22-month-old mice displayed reduced
weight bearing asymmetry, with both 15- and 22-
month old mice developing less severe early phase
mechanical hypersensitivity compared to young adult
mice. An age-related reduction in MIA-associated
microgliosis in the dorsal horn of the spinal cord was
also observed. These alterations are apparent despite no
gross differences when comparing knee pathology
between age groups. Furthermore, in a model of acute
inflammation, 22-month-old mice developed less me-
chanical hypersensitivity than 3-month-old mice, which
was coupled with a reduction in microglial activation.
The lack of obvious correlation between knee pathology
after MIA administration and altered behavioural re-
sponses with age mirrors the subpopulation of OA pa-
tients with reported knee pain but minimal knee pathol-
ogy, and vice versa. Notwithstanding the limitation of
the current study in which the extent of joint damage
was not quantified, our data provide support for signif-
icant contribution of central plasticity mechanisms to
OA pain and furthermore, that age-related changes with-
in the CNS could affect the manifestation of different
components of OA pain (Ogbonna et al. 2013; Rahman
and Dickenson 2015).
When assessing measures of ongoing pain using
weight bearing analysis and evoked referred allodynia
using von Frey filaments applied to the hind paw, effects
of age on the MIA model of OA are evident. Whilst 15-
month-old mice displayed weight bearing asymmetry
immediately from 3 days after MIA injection and to a
greater degree than 3-month-old counterparts, this pain
behaviour was significantly reduced in 22-month-old
mice and completely absent for the early phase of the
study. In a study by Gagliese and Melzack, 3- and 24-
month-old animals received intra-plantar injections of
the inflammogen formalin and had similar pain scores,
which were significantly less than for 18-month-old
animals who also received formalin injections
(Gagliese and Melzack 1999). They suggest that sensi-
tivity to persistent pain may peak at midlife, which
would support the data presented here. A possible ex-
planation could be neurochemical and neuroanatomical
changes that occur at mid-life and possibly alter the
response to tonic painful stimulation. These include
the onset of disinhibition by the degeneration of endog-
enous descending inhibitory pathways (Iwata et al.
1995) and a life-time peak in the dorsal root ganglia
neuronal number and size (Devor 1991), which could
lead to increased sensitivity to ongoing pain at mid-life.
With advancing age, there may be further changes with-
in the nociceptive pathway that impair nociceptive
transmission. In the life span of a mouse, it has been
reported that from 12 to 20 months of age, the mouse
peripheral nerve shows only mild signs of age-related
changes which progressively appear, with number and
density of nerve fibres beginning to decrease (Ceballos
et al. 1999). This type of age-related change would be
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expected to result in reduced nociceptive transmission to
the spinal cord. However, it may be that the peripheral
nerve changes are not robust enough to counteract the
possible increased excitability within the dorsal horn, as
a result of age-related disinhibiton (Iwata et al. 1995).
From 20months of age, however, nerves show a general
disorganisation, marked fibre loss and decreased density
of nerve fibres (Ceballos et al. 1999), which may be
sufficient to result in impaired nociceptive transmission.
The pattern of age-related effect on ongoing pain
determination was not replicated in the assessment of
referred mechanical allodynia. Both 15- and 22-month
old mice exhibited attenuated early phase responses to
MIA injection, with mechanical hypersensitivity devel-
oping later compared to 3-month-old mice. This early
phase pain response has been reported to be sensitive to
NSAIDs (Bove et al. 2003; Pomonis et al. 2005; Vonsy
et al. 2009), and it is generally accepted that it occurs as
a result of MIA-induced inflammation at the joint. The
absence of this response in aged mice suggests an age-
related reduction in the peripheral inflammatory re-
sponse. Interestingly, aged mice still developed signifi-
cant mechanical hypersensitivity in the late phase of the
MIA model, suggesting that there is still the capacity for
a large enough peripheral drive to activate dorsal horn
neurons; this increased peripheral drive may be coming
from sources other than nociceptive fibres. Wu and
Henry, reported changes in electrophysiological proper-
ties of non-knee joint afferents and Aβ fibre non-
nociceptive primary afferent neurons after surgical in-
duction of OAwhich may be involved in the pathogen-
esis of OA pain (Wu and Henry 2010). This also pro-
vides support for non-articular factors contributing to
OA pain and may offer some explanation for the lack of
correlation between joint pathology and severity of pain,
as well as incidence of pain in areas spatially distinct
from the OA affected joint. The mechanisms mediating
Aβ fibre responses remain unclear.
Peripheral inflammatory stimuli trigger central
microglial responses (Svensson et al. 2003; Clark
et al. 2007; Staniland et al. 2010) with consequent
proliferation and release of pro-inflammatory media-
tors. MIA-induced microgliosis was less robust with
age, supporting the concept that central inflammatory
responses, as well as peripheral inflammatory re-
sponses, are diminished with age. However, this hy-
pothesis is inconsistent with the fact that a significant
behavioural response is still seen at the same time
point in aged mice.
In summary, here, we provide evidence for an age-
related impairment of MIA-induced pain responses in
terms of nocifensive behaviour. Furthermore, we pro-
vide initial evidence that microglial response to periph-
eral damaging stimuli may be dysfunctional with ad-
vancing age.
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